CASILI, Giovanna
 Distribuzione geografica
Continente #
EU - Europa 4.860
NA - Nord America 4.852
AS - Asia 2.623
SA - Sud America 731
Continente sconosciuto - Info sul continente non disponibili 257
AF - Africa 89
OC - Oceania 7
Totale 13.419
Nazione #
US - Stati Uniti d'America 4.668
RU - Federazione Russa 2.674
SG - Singapore 1.028
CN - Cina 702
BR - Brasile 598
IE - Irlanda 516
IT - Italia 504
SE - Svezia 342
HK - Hong Kong 269
PL - Polonia 190
DE - Germania 162
VN - Vietnam 132
FR - Francia 111
IN - India 110
BD - Bangladesh 93
GB - Regno Unito 93
CA - Canada 71
MX - Messico 50
TR - Turchia 50
FI - Finlandia 49
UA - Ucraina 42
AR - Argentina 38
NL - Olanda 38
AT - Austria 33
ID - Indonesia 30
JP - Giappone 30
EC - Ecuador 28
IQ - Iraq 28
ES - Italia 26
ZA - Sudafrica 26
BE - Belgio 24
PK - Pakistan 24
VE - Venezuela 20
CO - Colombia 18
MA - Marocco 17
TN - Tunisia 16
UZ - Uzbekistan 16
CL - Cile 15
CR - Costa Rica 14
AE - Emirati Arabi Uniti 10
MY - Malesia 10
DK - Danimarca 9
NP - Nepal 9
PH - Filippine 9
CZ - Repubblica Ceca 8
JO - Giordania 8
SA - Arabia Saudita 8
AU - Australia 7
PS - Palestinian Territory 7
GT - Guatemala 6
IR - Iran 6
JM - Giamaica 6
KG - Kirghizistan 6
DO - Repubblica Dominicana 5
DZ - Algeria 5
IL - Israele 5
LT - Lituania 5
NI - Nicaragua 5
PE - Perù 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
BO - Bolivia 4
BY - Bielorussia 4
CI - Costa d'Avorio 4
ET - Etiopia 4
HN - Honduras 4
KE - Kenya 4
LB - Libano 4
PY - Paraguay 4
SV - El Salvador 4
TH - Thailandia 4
BB - Barbados 3
BG - Bulgaria 3
BZ - Belize 3
CH - Svizzera 3
EG - Egitto 3
HU - Ungheria 3
LA - Repubblica Popolare Democratica del Laos 3
PA - Panama 3
SC - Seychelles 3
AO - Angola 2
BS - Bahamas 2
EE - Estonia 2
GE - Georgia 2
GN - Guinea 2
GR - Grecia 2
KR - Corea 2
KZ - Kazakistan 2
MD - Moldavia 2
NO - Norvegia 2
PT - Portogallo 2
QA - Qatar 2
RO - Romania 2
RS - Serbia 2
SY - Repubblica araba siriana 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
Totale 13.145
Città #
Ashburn 927
Moscow 755
Singapore 535
Dublin 516
Chandler 411
San Jose 366
Dallas 302
Nyköping 280
Hong Kong 263
Beijing 189
Warsaw 185
Messina 139
Council Bluffs 136
Los Angeles 126
The Dalles 126
New York 121
Munich 90
Princeton 77
Santa Clara 61
Boardman 59
Ann Arbor 58
Lauterbourg 58
Medford 54
Ho Chi Minh City 42
São Paulo 41
Buffalo 40
Guangzhou 38
Redondo Beach 37
Des Moines 33
Phoenix 31
Jacksonville 29
Montreal 29
Orem 29
Rome 29
Frankfurt am Main 28
Tianjin 28
Brooklyn 27
Dearborn 26
Pune 26
Tokyo 26
Atlanta 23
Catania 23
Chennai 22
Hanoi 22
Brussels 21
Rio de Janeiro 21
Chicago 20
Wilmington 20
Denver 19
Jakarta 19
Milan 19
Shanghai 19
Turku 19
Vienna 18
North Bergen 17
Piazza Armerina 17
Düsseldorf 16
Houston 16
Johannesburg 16
Tashkent 16
Boston 15
Columbus 15
Hyderabad 15
London 15
Nuremberg 15
San Francisco 15
Amsterdam 14
Istanbul 14
Lappeenranta 14
Nanjing 14
Stockholm 14
Poplar 13
Seattle 13
Washington 13
Ankara 12
Baghdad 12
Belo Horizonte 12
Cambridge 12
Helsinki 12
Jinan 12
Marsala 12
Naples 12
Mexico City 11
San José 11
Dong Ket 10
Hangzhou 10
Palermo 10
Philadelphia 10
Quito 10
Zhengzhou 10
Brasília 9
Curitiba 9
Fortaleza 9
Guayaquil 9
Manchester 9
Mumbai 9
Querétaro 9
Santiago 9
Shenzhen 9
Toronto 9
Totale 7.223
Nome #
Dimethyl fumarate reduces inflammatory responses in experimental colitis 300
B-Cell Depletion with CD20 Antibodies as New Approach in the Treatment of Inflammatory and Immunological Events Associated with Spinal Cord Injury 231
B Cell depletion with CD20 antibodies as new approach in the treatment of inflammatory and immunological events associated with spinal cord 219
BAY-117082-driven NLRP3 inflammasome inhibition resolves nitro-glycerine (NTG) neuronal damage in in vivo model of migraine 212
Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of acute and chronic inflammation 212
Beneficial effect of KYP-2047, a propyl-oligopeptidase inhibitor, on oral squamous cell carcinoma 206
Co-Ultra PEALut Enhances Endogenous Repair Response Following Moderate Traumatic Brain Injury 205
Effect of a Product Containing Xyloglucan and Pea Protein on a Murine Model of Atopic Dermatitis 196
Dimethyl fumarate attenuates neuroinflammation and neurobehavioral deficits induced by experimental traumatic brain injury 194
Dimethyl fumarate alleviates the nitroglycerin (NTG)-induced migraine in mice 194
Effect of ultra-micronized-palmitoylethanolamide and acetyl-l-carnitine on experimental model of inflammatory pain 194
Efficacy of Xyloglucan against Escherichia coli Extraintestinal Urinary Tract Infection: An in vivo Study 188
Evaluation of a Product Containing Xyloglucan and Pea Protein on Skin Barrier Permeability 185
N-palmitoylethanolamide Prevents Parkinsonian Phenotypes in Aged Mice 183
A Combination of Xyloglucan, Pea Protein and Chia Seed Ameliorates Intestinal Barrier Integrity and Mucosa Functionality in a Rat Model of Constipation-Predominant Irritable Bowel Syndrome 182
A New Approach for the Treatment of Recurrent Vulvovaginal Candidiasis with a Combination of Pea Protein, Grape Seed Extract, and Lactic Acid Assessed In Vivo 174
The Neuroprotective Effect of Dimethyl Fumarate in an MPTP-Mouse Model of Parkinson's Disease: Involvement of Reactive Oxygen Species/Nuclear Factor-κB/Nuclear Transcription Factor Related to NF-E2 173
TAK1 inhibitor enhances the therapeutic treatment for glioblastoma 172
Efficacy of an oral suspension containing xyloglucan and pea proteins on a murine model of gastroesophageal reflux disease 170
Dimethyl Fumarate (DMF) Alleviated Post-Operative (PO) Pain through the N-Methyl-d-Aspartate (NMDA) Receptors 170
Therapeutic potential of flavonoids in the treatment of chronic venous insufficiency 169
Adenosine Targeting as a New Strategy to Decrease Glioblastoma Aggressiveness 168
Autophagy and Liver Diseases 164
Efficacy of a Product Containing Xyloglucan and Pea Protein on Intestinal Barrier Function in a Partial Restraint Stress Animal Model 164
The in vivo pharmacological manipulation of the Nrf-2 pathway and its therapeutic significance in brain diseases, with a possible implication in H2S-regulated lipidic metabolism 163
The protective role of prolyl oligopeptidase (pop) inhibition in acute lung injury induced by intestinal ischemia-reperfusion 163
Potential Therapeutic Effects of PPAR Ligands in Glioblastoma 155
Therapeutic Potential of BAY-117082, a Selective NLRP3 Inflammasome Inhibitor, on Metastatic Evolution in Human Oral Squamous Cell Carcinoma (OSCC) 146
Fumaric acid esters attenuate degeneration and promote functional recovery following Parkinson’s disease 145
KYP-2047, an inhibitor of prolyl-oligopeptidase, reduces glioblastoma proliferation through angiogenesis and apoptosis modulation 145
NLRP3 Inflammasome Inhibitor BAY-117082 Reduces Oral Squamous Cell Carcinoma Progression 144
Role of calixarene in chemotherapy delivery strategies 144
Sodium Propionate Contributes to Tumor Cell Growth Inhibition through PPAR-γ Signaling 141
bFGF-like Activity Supported Tissue Regeneration, Modulated Neuroinflammation, and Rebalanced Ca2+ Homeostasis following Spinal Cord Injury 141
Neuroprotective effects of GSK-343 in an in vivo model of MPTP-induced nigrostriatal degeneration 140
Towards new therapies for glioblastoma treatment: role of Dkk-3 and Claudin-5 140
GSK343, an Inhibitor of Enhancer of Zeste Homolog 2, Reduces Glioblastoma Progression through Inflammatory Process Modulation: Focus on Canonical and Non-Canonical NF-κB/IκBα Pathways 139
Multiple mechanisms of dimethyl fumarate in amyloid β-induced neurotoxicity in human neuronal cells 139
Fumaric Acid Esters Attenuate Secondary Degeneration and Promote Functional Recovery Following Experimental Spinal Cord Injury 139
Evaluating the Protective Properties of a Xyloglucan-Based Nasal Spray in a Mouse Model of Allergic Rhinitis 139
The protective role of prolyl oligopeptidase (Pop) inhibition in kidney injury induced by renal ischemia–reperfusion 139
Towards new therapies for glioblastoma treatment: role of Dkk-3 and Claudin-5. 137
TLR-4/Wnt modulation as new therapeutic strategy in the treatment of glioblastomas 137
An RNAi-Mediated Reduction in Transcription Factor Nrf-2 Blocks the Positive Effects of Dimethyl Fumarate on Metabolic Stress in Alzheimer's Disease 133
Protective effects of xyloglucan in association with the polysaccharide gelose in an experimental model of gastroenteritis and urinary tract infections 133
The anti-inflammatory and antioxidant effects of sodium propionate 133
Poly (Adp-ribose) polymerase inhibitor, abt888, improved cisplatin effect in human oral cell carcinoma 133
Benzyl isothiocyanate suppresses development of thyroid carcinoma by regulating both autophagy and apoptosis pathway 132
Synergic therapeutic potential of PEA-Um treatment and NAAA enzyme silencing in the management of neuroinflammation 131
A Topical Combination of Xyloglucan and Pea Protein Effectively Manages Oral Ulcers In Vivo 130
Efficacy of the Radical Scavenger, Tempol, to Reduce Inflammation and Oxidative Stress in a Murine Model of Atopic Dermatitis 129
Inhibition of Prolyl Oligopeptidase Prevents Consequences of Reperfusion following Intestinal Ischemia 129
Modulation of NLRP3 inflammasome attenuated inflammatory response associated to diarrhea-predominant irritable bowel syndrome 128
The inhibition of prolyl oligopeptidase as new target to counteract chronic venous insufficiency: Findings in a mouse model 125
Effect of pea protein plus grape seed dry extract on a murine model of Candida albicans induced vaginitis 125
Efficacy of a Novel Therapeutic, Based on Natural Ingredients and Probiotics, in a Murine Model of Multiple Food Intolerance and Maldigestion 124
Pea-oxa mitigates oxaliplatin-induced painful neuropathy through nf-κb/nrf-2 axis 121
Role of ABT888, a Novel Poly(ADP-Ribose) Polymerase (PARP) Inhibitor in Countering Autophagy and Apoptotic Processes Associated to Spinal Cord Injury 120
Supplementation with SCFAs Re-Establishes Microbiota Composition and Attenuates Hyperalgesia and Pain in a Mouse Model of NTG-Induced Migraine 119
Protective effect of sodium propionate in Aβ1-42 -induced neurotoxicity and spinal cord trauma 119
Modulation of Dkk-3 and claudin-5 as new therapeutic strategy in the treatment of meningiomas 119
Immunomodulatory effect of microglia-released cytokines in gliomas 119
Topical delivery of curcumin by choline-calix[4]arene-based nanohydrogel improves its therapeutic effect on a psoriasis mouse model 117
Traumatic Brain Injury Leads to Development of Parkinson's Disease in Mice 114
Effect of a combination of pea protein, grape seed extract and lactic acid in an in vivo model of bacterial vaginosis 111
KRAS-SOS-1 Inhibition as New Pharmacological Target to Counteract Anaplastic Thyroid Carcinoma (ATC) 109
Therapeutic Potential of Dimethyl Fumarate in Counteract Oral Squamous Cell Carcinoma Progression by Modulating Apoptosis, Oxidative Stress and Epithelial–Mesenchymal Transition 108
Evaluation of the Efficacy of Xyloglucan, Pea Protein and Opuntia ficus-indica Extract in a Preclinical Model of Psoriasis 105
Treatment with luteolin improves lipopolysaccharide‐induced periodontal diseases in rats 105
SCFA Treatment Alleviates Pathological Signs of Migraine and Related Intestinal Alterations in a Mouse Model of NTG-Induced Migraine 103
Prolyl oligopeptidase inhibition ameliorates experimental pulmonary fibrosis both in vivo and in vitro 101
Magnesium prevents both H2O2- and NEM-induced oxidative damage at Band 3 protein level in human erythrocytes. 101
Role of Basic Fibroblast Growth Factor in Cancer: Biological Activity, Targeted Therapies, and Prognostic Value 100
Properties of a new food supplement containing Actinia equina extract 99
Micronized palmitoylethanolamide (PEA-m): a new pharmacological strategy to prevent neurodegenerative disease associated to the old age 98
Neutralization of extracellular NAMPT (nicotinamide phosphoribosyltransferase) ameliorates experimental murine colitis 97
The inhibition of mammalian target of rapamycin (mTOR) in improving inflammatory response after traumatic brain injury 96
The Protective Role of Troxerutin (Trox) in Counteracting Anaplastic Thyroid Carcinoma (ATC) Progression 95
Sodium Butyrate Exerts Neuroprotective Effects in Spinal Cord Injury 94
Tlr7/8 in the pathogenesis of parkinson’s disease 94
Ulva pertusa, a Marine Green Alga, Attenuates DNBS-Induced Colitis Damage via NF-κB/Nrf2/SIRT1 Signaling Pathways 93
The Transcription Factor Nrf2 Mediates the Effects of Antrodia camphorata Extract on Neuropathological Changes in a Mouse Model of Parkinson’s Disease 93
TBK1 Inhibitor Exerts Antiproliferative Effect on Glioblastoma Multiforme Cells 93
Corrigendum to “Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of acute and chronic inflammation” [Biochem. Pharmacol. 119 (2016) 27–41, (S0006295216302611), (10.1016/j.bcp.2016.09.001)] 92
The Pivotal Role of Protein Phosphatase 2A (PP2A) in Brain Tumors 91
SUN11602, a bFGF mimetic, modulated neuroinflammation, apoptosis and calcium-binding proteins in an in vivo model of MPTP-induced nigrostriatal degeneration 89
The Inhibition of Prolyl Endopeptidase (PREP) by KYP-2047 Treatment to Reduce Myocardial Ischemia/Reperfusion Injury 89
PI3K/mTOR Signaling Pathway Dual Inhibition for the Management of Neuroinflammation: Novel Insights from In Vitro Models 87
Selenium-Binding Protein 1 (SELENBP1) Supports Hydrogen Sulfide Biosynthesis and Adipogenesis 87
PF-04691502, a PI3K/mTOR Dual Inhibitor, Ameliorates AD-like Pathology in a Mouse Model of AD 85
Protein Kinase Inhibitors as a New Target for Immune System Modulation and Brain Cancer Management 85
FeTPPS reduces secondary damage and improves neurobehavioral functions after traumatic brain injury 80
Inhibition of LRRK2 Attenuates Depression-Related Symptoms in Mice with Moderate Traumatic Brain Injury 78
DKK3 Expression in Glioblastoma: Correlations with Biomolecular Markers 73
Fumaric Acid Esters Attenuate Secondary Degeneration Following Spinal Cord Injury 60
The Role of miR-128 in Neurodegenerative Diseases 53
Aesculus hippocastanum Extract Exerts Neuroprotective Effects in an MPP+-Induced Parkinson's Disease Model via PPARγ Activation 50
GIT 27 modulates TLR4/Src/NOX2 signaling pathway: A potential therapeutic strategy to decrease neuroinflammation, oxidative stress and neuronal cell death in Parkinson's disease 50
Overview on Common Genes Involved in the Onset of Glioma and on the Role of Migraine as Risk Factor: Predictive Biomarkers or Therapeutic Targets? 49
null 48
Totale 13.135
Categoria #
all - tutte 49.538
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.538


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022407 0 0 0 13 24 4 19 23 33 13 69 209
2022/20231.540 118 153 67 114 96 175 19 73 648 17 42 18
2023/2024527 23 70 28 48 38 172 8 21 1 20 7 91
2024/20252.024 34 26 70 102 91 87 84 323 504 162 244 297
2025/20266.957 424 335 453 436 623 1.395 801 840 863 396 154 237
2026/20271.187 158 286 334 409 0 0 0 0 0 0 0 0
Totale 13.419